meglumine antimoniate has been researched along with Hypotension in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Garcia-Cordoba, F; Gonzalez Diaz, G; Ortuño, FJ; Segovia, M | 1 |
1 other study(ies) available for meglumine antimoniate and Hypotension
Article | Year |
---|---|
Fatal visceral leishmaniasis, with massive bone-marrow infection, in an immunosuppressed but HIV-negative Spanish patient, after the initiation of treatment with meglumine antimoniate.
Topics: Antiprotozoal Agents; Bone Marrow; Bone Marrow Diseases; Fatal Outcome; Glucocorticoids; HIV Seronegativity; Humans; Hypotension; Immunocompromised Host; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Prednisone; Pulmonary Disease, Chronic Obstructive | 2005 |